SciELO - Scientific Electronic Library Online

 
vol.29 número3Confirmation of spotted-fever group and typhus group rickettsiosis cases through a three-month hospital-based sentinel surveillance of acute undifferentiated febrile illness in the municipality of Santander de Quilichao, Cauca, ColombiaIncidental diagnosis of pulmonary tuberculosis in patients referred for diagnostic bronchoscopy or clinical follow-up due to malignant tumor disease: a cross-sectional study índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Infectio

versão impressa ISSN 0123-9392

Resumo

PELAEZ-MARTINEZ, Juan David et al. Screening and Distribution of High-Risk HPV Genotypes in Women from Cali, Colombia in 2023: Results from the Por Ti Mujer Program. Infect. [online]. 2025, vol.29, n.3, pp.150-158.  Epub 10-Set-2025. ISSN 0123-9392.  https://doi.org/10.22354/24223794.1236.

Introduction:

Persistent high-risk human papillomavirus (HPV) infections are strongly associated with cervical cancer, the leading cause of cancer-related deaths among women aged 30-59 years in Colombia. This study presents the screening results and distribution of high-risk HPV genotypes in women enrolled in the Por Ti Mujer programme in Cali, Colombia.

Materials and Methods:

A cross-sectional descriptive observational study was conducted using medical records of adult women screened using conventional cytology, high-risk HPV DNA testing, and visual inspection with acetic acid and lugol's iodine. Data were collected between January and June 2023 using the Por Ti Mujer program.

Results:

A total of 15,130 records were analyzed. Overall positivity, regardless of screening method, was 10.2%; positivity for HPV DNA was 15.2%, and positivity for cytology was 5.4%. Women aged 30-65 years and those in the contributory health insurance scheme group had higher rates of abnormal results. The most frequent high-risk HPV genotypes were 56-59-66 (21.2%), 33-39-68 (17.0%), 16 (13.8%), 33-58 (12.1%), and 52 (11.1%).

Discussion:

The HPV DNA positivity rate in the Por Ti Mujer program (15.2%) was higher than the global average (10.4%), but lower than the regional Latin American estimate (16.1%). The most prevalent genotypes were 56-59-66 and 33-39-68.

Palavras-chave : Papillomavirus infection; mass screening; genotype; cervical cancer; cytology.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )